Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (401-410 of 464) with videos related to

Pageof 47
Sort By:
The Lancet. Gastroenterology & Hepatology|June 12, 2025
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trialsChristopher Ma, Reena Khanna, Bryan R Maguire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trialJurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2018
Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic ReviewChristopher Ma, Bram D van Rhijn, Vipul Jairath, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's diseaseRichard N Fedorak, Brian G Feagan, Naomi Hotte, et al.
The New England Journal of Medicine|February 27, 2004
Infliximab maintenance therapy for fistulizing Crohn's diseaseBruce E Sands, Frank H Anderson, Charles N Bernstein, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Inflammatory Bowel Diseases|November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's DiseaseJurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Inflammatory Bowel Diseases|June 29, 2019
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's DiseaseWilliams Turpin, Osvaldo Espin-Garcia, Larbi Bedrani, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
Gut|October 18, 2015
Development and validation of a histological index for UCMahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Pageof 47

Showing results (401-410 of 464) with videos related to

Sort By:
Pageof 47
The Lancet. Gastroenterology & Hepatology|June 12, 2025
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trialsChristopher Ma, Reena Khanna, Bryan R Maguire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trialJurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2018
Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic ReviewChristopher Ma, Bram D van Rhijn, Vipul Jairath, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's diseaseRichard N Fedorak, Brian G Feagan, Naomi Hotte, et al.
The New England Journal of Medicine|February 27, 2004
Infliximab maintenance therapy for fistulizing Crohn's diseaseBruce E Sands, Frank H Anderson, Charles N Bernstein, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Inflammatory Bowel Diseases|November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's DiseaseJurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Inflammatory Bowel Diseases|June 29, 2019
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's DiseaseWilliams Turpin, Osvaldo Espin-Garcia, Larbi Bedrani, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
Gut|October 18, 2015
Development and validation of a histological index for UCMahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Pageof 47